Breakthrough
Palmitoylethanolamide (PEA) for Chronic Pain and Neuroinflammation: The Trial Record
Palmitoylethanolamide is an endogenous fatty-acid amide produced on demand in inflamed tissue. Originally characterized at the University of Pavia in the 1990s, PEA modulates non-neuronal mast-cell and microglial activation through PPAR-alp…